Advertisement
WorldUnited States & Canada

Preet Bharara was reportedly investigating one of Donald Trump’s cabinet members before being fired as US attorney

Bharara was one of 46 US attorneys asked to resign after Trump took office

2-MIN READ2-MIN
Preet Bharara, former US attorney for the Southern District of New York. Photo: AFP
Associated Press

The non-profit journalism outlet ProPublica reported on Friday that former US Attorney Preet Bharara was investigating the stock trades of Health and Human Services Secretary Tom Price when the White House fired him last week.

An excerpt from the ProPublica report said: “The investigation of Price’s trades by the US Attorney’s Office for the Southern District of New York, which hasn’t been previously disclosed, was under way at the time of Bharara’s dismissal, said the person.”

Bharara was one of 46 US attorneys asked to resign after President Donald Trump took office. It is standard for new presidents to replace those officials with their own appointees. But Bharara’s firing came as a surprise because the president had met with him at Trump Tower soon after the election. As he left that meeting, Bharara told reporters Trump asked if he would be prepared to remain in his post, and said that he had agreed to stay on.

Americans deserve better than an HHS secretary who uses his public office for self-enrichment
Michael Smith, spokesman for Georgia Democratic Party

For the duration of his Senate confirmation process, Price was unable to kick stories about his stock trades as a Georgia congressman. Several news outlets reported that Price traded hundreds of thousands of dollars’ worth of shares of health-related companies while he was serving on House committees that had jurisdiction over the policy area.

Advertisement

That in itself is not illegal, but ethics watchdogs Senate Democrats raised questions about whether the trades ran aground of congressional ethics laws that bar lawmakers from trading stocks based off non-public information acquired through their jobs.

Of particular interest were his trades in the Australian tech company Innate Immunotherapeutics. Price had purchased US$10,000 in stock in January 2015 and later that year invested between US$50,000 and US$100,000 – days after colleague Chris Collins, R-N.Y., who was on the company’s board of directors, purchased 10 times that amount.

Advertisement

Price’s Republican allies brushed aside Democrats’ calls for an investigation, and Price repeatedly insisted that all of his trades were kosher. He was confirmed last month on a party-line vote.

Advertisement
Select Voice
Select Speed
1.00x